BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10860926)

  • 1. Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors.
    Huss JM; Kasper CB
    Mol Pharmacol; 2000 Jul; 58(1):48-57. PubMed ID: 10860926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential glucocorticoid responses of CYP3A23 and CYP3A2 are mediated by selective binding of orphan nuclear receptors.
    Huss JM; Wang SI; Kasper CB
    Arch Biochem Biophys; 1999 Dec; 372(2):321-32. PubMed ID: 10600171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23.
    Shi D; Yang D; Yan B
    Biochem Pharmacol; 2010 Oct; 80(8):1274-83. PubMed ID: 20599767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression.
    Huss JM; Kasper CB
    J Biol Chem; 1998 Jun; 273(26):16155-62. PubMed ID: 9632670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element.
    El-Sankary W; Bombail V; Gibson GG; Plant N
    Drug Metab Dispos; 2002 Sep; 30(9):1029-34. PubMed ID: 12167569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of DNA-binding proteins required for glucocorticoid induction of CYP3A23.
    Quattrochi LC; Yockey CB; Barwick JL; Guzelian PS
    Arch Biochem Biophys; 1998 Jan; 349(2):251-60. PubMed ID: 9448712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics.
    LeCluyse EL
    Chem Biol Interact; 2001 May; 134(3):283-9. PubMed ID: 11336976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous substitution of phenylalanine-305 and aspartate-318 of rat pregnane X receptor with the corresponding human residues abolishes the ability to transactivate the CYP3A23 promoter.
    Song X; Li Y; Liu J; Mukundan M; Yan B
    J Pharmacol Exp Ther; 2005 Feb; 312(2):571-82. PubMed ID: 15367577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators.
    Pascussi JM; Drocourt L; Fabre JM; Maurel P; Vilarem MJ
    Mol Pharmacol; 2000 Aug; 58(2):361-72. PubMed ID: 10908304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element.
    Schuetz EG; Brimer C; Schuetz JD
    Mol Pharmacol; 1998 Dec; 54(6):1113-7. PubMed ID: 9855641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23.
    Ma Y; Sachdeva K; Liu J; Song X; Li Y; Yang D; Deng R; Chichester CO; Yan B
    Biochem Pharmacol; 2005 May; 69(9):1363-71. PubMed ID: 15826607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif.
    Huss JM; Wang SI; Astrom A; McQuiddy P; Kasper CB
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4666-70. PubMed ID: 8643461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
    Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
    Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes.
    Wang H; Faucette SR; Gilbert D; Jolley SL; Sueyoshi T; Negishi M; LeCluyse EL
    Drug Metab Dispos; 2003 May; 31(5):620-30. PubMed ID: 12695351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha.
    Ferguson SS; Chen Y; LeCluyse EL; Negishi M; Goldstein JA
    Mol Pharmacol; 2005 Sep; 68(3):747-57. PubMed ID: 15933212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor.
    Ripp SL; Fitzpatrick JL; Peters JM; Prough RA
    Drug Metab Dispos; 2002 May; 30(5):570-5. PubMed ID: 11950789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.
    Pascussi JM; Drocourt L; Gerbal-Chaloin S; Fabre JM; Maurel P; Vilarem MJ
    Eur J Biochem; 2001 Dec; 268(24):6346-58. PubMed ID: 11737189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression.
    Cooper BW; Cho TM; Thompson PM; Wallace AD
    Toxicol Sci; 2008 Jun; 103(2):268-77. PubMed ID: 18332045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation.
    Dvorak Z; Modriansky M; Pichard-Garcia L; Balaguer P; Vilarem MJ; Ulrichová J; Maurel P; Pascussi JM
    Mol Pharmacol; 2003 Jul; 64(1):160-9. PubMed ID: 12815172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
    Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
    Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.